nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—urinary bladder cancer—kidney cancer	0.39	0.597	CtDrD
Thiotepa—sarcoma—kidney cancer	0.264	0.403	CtDrD
Thiotepa—CYP3A4—Everolimus—kidney cancer	0.0435	0.223	CbGbCtD
Thiotepa—CYP3A4—Temsirolimus—kidney cancer	0.0294	0.15	CbGbCtD
Thiotepa—CYP2B6—Sorafenib—kidney cancer	0.0292	0.149	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—kidney cancer	0.0177	0.0905	CbGbCtD
Thiotepa—CYP3A4—Pazopanib—kidney cancer	0.0154	0.079	CbGbCtD
Thiotepa—CYP3A4—Erlotinib—kidney cancer	0.011	0.0564	CbGbCtD
Thiotepa—CYP3A4—Paclitaxel—kidney cancer	0.0101	0.0516	CbGbCtD
Thiotepa—CYP3A4—Sorafenib—kidney cancer	0.00896	0.0458	CbGbCtD
Thiotepa—CYP3A4—Vinblastine—kidney cancer	0.00885	0.0452	CbGbCtD
Thiotepa—CYP3A4—Vincristine—kidney cancer	0.0087	0.0445	CbGbCtD
Thiotepa—CYP3A4—Sunitinib—kidney cancer	0.00726	0.0371	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—kidney cancer	0.00544	0.0278	CbGbCtD
Thiotepa—Paraesthesia—Vincristine—kidney cancer	5.89e-05	0.000391	CcSEcCtD
Thiotepa—Agitation—Paclitaxel—kidney cancer	5.87e-05	0.000389	CcSEcCtD
Thiotepa—Rash—Everolimus—kidney cancer	5.85e-05	0.000388	CcSEcCtD
Thiotepa—Dermatitis—Everolimus—kidney cancer	5.85e-05	0.000388	CcSEcCtD
Thiotepa—Headache—Vinblastine—kidney cancer	5.84e-05	0.000387	CcSEcCtD
Thiotepa—Headache—Everolimus—kidney cancer	5.82e-05	0.000386	CcSEcCtD
Thiotepa—Abdominal pain—Dactinomycin—kidney cancer	5.8e-05	0.000385	CcSEcCtD
Thiotepa—Body temperature increased—Dactinomycin—kidney cancer	5.8e-05	0.000385	CcSEcCtD
Thiotepa—Asthenia—Sorafenib—kidney cancer	5.78e-05	0.000384	CcSEcCtD
Thiotepa—Cardiac failure—Doxorubicin—kidney cancer	5.75e-05	0.000381	CcSEcCtD
Thiotepa—Leukopenia—Paclitaxel—kidney cancer	5.71e-05	0.000379	CcSEcCtD
Thiotepa—Hypersensitivity—Sunitinib—kidney cancer	5.71e-05	0.000379	CcSEcCtD
Thiotepa—Decreased appetite—Vincristine—kidney cancer	5.7e-05	0.000378	CcSEcCtD
Thiotepa—Pruritus—Sorafenib—kidney cancer	5.7e-05	0.000378	CcSEcCtD
Thiotepa—Vomiting—Erlotinib—kidney cancer	5.7e-05	0.000378	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Gemcitabine—kidney cancer	5.67e-05	0.000376	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Vincristine—kidney cancer	5.66e-05	0.000376	CcSEcCtD
Thiotepa—Fatigue—Vincristine—kidney cancer	5.66e-05	0.000375	CcSEcCtD
Thiotepa—Rash—Erlotinib—kidney cancer	5.65e-05	0.000375	CcSEcCtD
Thiotepa—Dermatitis—Erlotinib—kidney cancer	5.64e-05	0.000374	CcSEcCtD
Thiotepa—Eye disorder—Capecitabine—kidney cancer	5.62e-05	0.000373	CcSEcCtD
Thiotepa—Headache—Erlotinib—kidney cancer	5.61e-05	0.000372	CcSEcCtD
Thiotepa—Tinnitus—Capecitabine—kidney cancer	5.61e-05	0.000372	CcSEcCtD
Thiotepa—Constipation—Vincristine—kidney cancer	5.61e-05	0.000372	CcSEcCtD
Thiotepa—Pain—Vincristine—kidney cancer	5.61e-05	0.000372	CcSEcCtD
Thiotepa—Paraesthesia—Gemcitabine—kidney cancer	5.59e-05	0.000371	CcSEcCtD
Thiotepa—Cardiac disorder—Capecitabine—kidney cancer	5.59e-05	0.00037	CcSEcCtD
Thiotepa—Cough—Paclitaxel—kidney cancer	5.57e-05	0.00037	CcSEcCtD
Thiotepa—Asthenia—Sunitinib—kidney cancer	5.56e-05	0.000369	CcSEcCtD
Thiotepa—Nausea—Vinblastine—kidney cancer	5.54e-05	0.000367	CcSEcCtD
Thiotepa—Somnolence—Gemcitabine—kidney cancer	5.53e-05	0.000367	CcSEcCtD
Thiotepa—Convulsion—Paclitaxel—kidney cancer	5.53e-05	0.000367	CcSEcCtD
Thiotepa—Nausea—Everolimus—kidney cancer	5.52e-05	0.000366	CcSEcCtD
Thiotepa—Diarrhoea—Sorafenib—kidney cancer	5.51e-05	0.000366	CcSEcCtD
Thiotepa—Hypertension—Paclitaxel—kidney cancer	5.51e-05	0.000366	CcSEcCtD
Thiotepa—Pruritus—Sunitinib—kidney cancer	5.49e-05	0.000364	CcSEcCtD
Thiotepa—Angiopathy—Capecitabine—kidney cancer	5.46e-05	0.000362	CcSEcCtD
Thiotepa—Immune system disorder—Capecitabine—kidney cancer	5.44e-05	0.000361	CcSEcCtD
Thiotepa—Myalgia—Paclitaxel—kidney cancer	5.44e-05	0.000361	CcSEcCtD
Thiotepa—Arthralgia—Paclitaxel—kidney cancer	5.44e-05	0.000361	CcSEcCtD
Thiotepa—Mediastinal disorder—Capecitabine—kidney cancer	5.42e-05	0.00036	CcSEcCtD
Thiotepa—Anxiety—Paclitaxel—kidney cancer	5.42e-05	0.000359	CcSEcCtD
Thiotepa—Decreased appetite—Gemcitabine—kidney cancer	5.41e-05	0.000359	CcSEcCtD
Thiotepa—Hypersensitivity—Dactinomycin—kidney cancer	5.41e-05	0.000359	CcSEcCtD
Thiotepa—Chills—Capecitabine—kidney cancer	5.4e-05	0.000358	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	5.4e-05	0.000358	CcSEcCtD
Thiotepa—Arrhythmia—Capecitabine—kidney cancer	5.38e-05	0.000357	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Gemcitabine—kidney cancer	5.37e-05	0.000356	CcSEcCtD
Thiotepa—Fatigue—Gemcitabine—kidney cancer	5.37e-05	0.000356	CcSEcCtD
Thiotepa—Gastrointestinal pain—Vincristine—kidney cancer	5.36e-05	0.000356	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—kidney cancer	5.33e-05	0.000354	CcSEcCtD
Thiotepa—Dizziness—Sorafenib—kidney cancer	5.33e-05	0.000354	CcSEcCtD
Thiotepa—Pain—Gemcitabine—kidney cancer	5.32e-05	0.000353	CcSEcCtD
Thiotepa—Constipation—Gemcitabine—kidney cancer	5.32e-05	0.000353	CcSEcCtD
Thiotepa—Nausea—Erlotinib—kidney cancer	5.32e-05	0.000353	CcSEcCtD
Thiotepa—Alopecia—Capecitabine—kidney cancer	5.32e-05	0.000353	CcSEcCtD
Thiotepa—Diarrhoea—Sunitinib—kidney cancer	5.31e-05	0.000352	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—kidney cancer	5.27e-05	0.00035	CcSEcCtD
Thiotepa—Mental disorder—Capecitabine—kidney cancer	5.27e-05	0.00035	CcSEcCtD
Thiotepa—Asthenia—Dactinomycin—kidney cancer	5.27e-05	0.000349	CcSEcCtD
Thiotepa—Confusional state—Paclitaxel—kidney cancer	5.25e-05	0.000348	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—kidney cancer	5.25e-05	0.000348	CcSEcCtD
Thiotepa—Erythema—Capecitabine—kidney cancer	5.24e-05	0.000348	CcSEcCtD
Thiotepa—Malnutrition—Capecitabine—kidney cancer	5.24e-05	0.000348	CcSEcCtD
Thiotepa—Dehydration—Doxorubicin—kidney cancer	5.22e-05	0.000346	CcSEcCtD
Thiotepa—Body temperature increased—Vincristine—kidney cancer	5.19e-05	0.000344	CcSEcCtD
Thiotepa—Abdominal pain—Vincristine—kidney cancer	5.19e-05	0.000344	CcSEcCtD
Thiotepa—Infection—Paclitaxel—kidney cancer	5.18e-05	0.000343	CcSEcCtD
Thiotepa—Dizziness—Sunitinib—kidney cancer	5.13e-05	0.00034	CcSEcCtD
Thiotepa—Feeling abnormal—Gemcitabine—kidney cancer	5.13e-05	0.00034	CcSEcCtD
Thiotepa—Vomiting—Sorafenib—kidney cancer	5.12e-05	0.00034	CcSEcCtD
Thiotepa—Nervous system disorder—Paclitaxel—kidney cancer	5.11e-05	0.000339	CcSEcCtD
Thiotepa—Thrombocytopenia—Paclitaxel—kidney cancer	5.1e-05	0.000338	CcSEcCtD
Thiotepa—Tachycardia—Paclitaxel—kidney cancer	5.09e-05	0.000337	CcSEcCtD
Thiotepa—Rash—Sorafenib—kidney cancer	5.08e-05	0.000337	CcSEcCtD
Thiotepa—Dermatitis—Sorafenib—kidney cancer	5.08e-05	0.000337	CcSEcCtD
Thiotepa—Back pain—Capecitabine—kidney cancer	5.07e-05	0.000336	CcSEcCtD
Thiotepa—Skin disorder—Paclitaxel—kidney cancer	5.06e-05	0.000336	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	5.05e-05	0.000335	CcSEcCtD
Thiotepa—Headache—Sorafenib—kidney cancer	5.05e-05	0.000335	CcSEcCtD
Thiotepa—Diarrhoea—Dactinomycin—kidney cancer	5.02e-05	0.000333	CcSEcCtD
Thiotepa—Anorexia—Paclitaxel—kidney cancer	4.97e-05	0.000329	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.95e-05	0.000328	CcSEcCtD
Thiotepa—Vision blurred—Capecitabine—kidney cancer	4.94e-05	0.000328	CcSEcCtD
Thiotepa—Vomiting—Sunitinib—kidney cancer	4.93e-05	0.000327	CcSEcCtD
Thiotepa—Body temperature increased—Gemcitabine—kidney cancer	4.92e-05	0.000326	CcSEcCtD
Thiotepa—Rash—Sunitinib—kidney cancer	4.89e-05	0.000324	CcSEcCtD
Thiotepa—Dermatitis—Sunitinib—kidney cancer	4.89e-05	0.000324	CcSEcCtD
Thiotepa—Headache—Sunitinib—kidney cancer	4.86e-05	0.000322	CcSEcCtD
Thiotepa—Anaemia—Capecitabine—kidney cancer	4.84e-05	0.000321	CcSEcCtD
Thiotepa—Hypersensitivity—Vincristine—kidney cancer	4.83e-05	0.000321	CcSEcCtD
Thiotepa—Nausea—Sorafenib—kidney cancer	4.79e-05	0.000318	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.75e-05	0.000315	CcSEcCtD
Thiotepa—Asthenia—Vincristine—kidney cancer	4.71e-05	0.000312	CcSEcCtD
Thiotepa—Leukopenia—Capecitabine—kidney cancer	4.69e-05	0.000311	CcSEcCtD
Thiotepa—Paraesthesia—Paclitaxel—kidney cancer	4.68e-05	0.00031	CcSEcCtD
Thiotepa—Vomiting—Dactinomycin—kidney cancer	4.67e-05	0.00031	CcSEcCtD
Thiotepa—Somnolence—Paclitaxel—kidney cancer	4.63e-05	0.000307	CcSEcCtD
Thiotepa—Rash—Dactinomycin—kidney cancer	4.63e-05	0.000307	CcSEcCtD
Thiotepa—Nausea—Sunitinib—kidney cancer	4.61e-05	0.000306	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—kidney cancer	4.6e-05	0.000305	CcSEcCtD
Thiotepa—Dyspepsia—Paclitaxel—kidney cancer	4.59e-05	0.000304	CcSEcCtD
Thiotepa—Cough—Capecitabine—kidney cancer	4.57e-05	0.000303	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—kidney cancer	4.53e-05	0.000301	CcSEcCtD
Thiotepa—Decreased appetite—Paclitaxel—kidney cancer	4.53e-05	0.0003	CcSEcCtD
Thiotepa—Hypertension—Capecitabine—kidney cancer	4.52e-05	0.0003	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.5e-05	0.000298	CcSEcCtD
Thiotepa—Fatigue—Paclitaxel—kidney cancer	4.49e-05	0.000298	CcSEcCtD
Thiotepa—Diarrhoea—Vincristine—kidney cancer	4.49e-05	0.000298	CcSEcCtD
Thiotepa—Asthenia—Gemcitabine—kidney cancer	4.47e-05	0.000296	CcSEcCtD
Thiotepa—Arthralgia—Capecitabine—kidney cancer	4.46e-05	0.000296	CcSEcCtD
Thiotepa—Myalgia—Capecitabine—kidney cancer	4.46e-05	0.000296	CcSEcCtD
Thiotepa—Pain—Paclitaxel—kidney cancer	4.46e-05	0.000296	CcSEcCtD
Thiotepa—Constipation—Paclitaxel—kidney cancer	4.46e-05	0.000296	CcSEcCtD
Thiotepa—Anxiety—Capecitabine—kidney cancer	4.44e-05	0.000295	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.43e-05	0.000294	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—kidney cancer	4.41e-05	0.000293	CcSEcCtD
Thiotepa—Pruritus—Gemcitabine—kidney cancer	4.4e-05	0.000292	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—kidney cancer	4.37e-05	0.00029	CcSEcCtD
Thiotepa—Nausea—Dactinomycin—kidney cancer	4.36e-05	0.000289	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—kidney cancer	4.35e-05	0.000288	CcSEcCtD
Thiotepa—Dizziness—Vincristine—kidney cancer	4.34e-05	0.000288	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—kidney cancer	4.32e-05	0.000287	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—kidney cancer	4.32e-05	0.000287	CcSEcCtD
Thiotepa—Confusional state—Capecitabine—kidney cancer	4.31e-05	0.000286	CcSEcCtD
Thiotepa—Feeling abnormal—Paclitaxel—kidney cancer	4.29e-05	0.000285	CcSEcCtD
Thiotepa—Gastrointestinal pain—Paclitaxel—kidney cancer	4.26e-05	0.000283	CcSEcCtD
Thiotepa—Diarrhoea—Gemcitabine—kidney cancer	4.26e-05	0.000282	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—kidney cancer	4.25e-05	0.000282	CcSEcCtD
Thiotepa—Infection—Capecitabine—kidney cancer	4.25e-05	0.000282	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—kidney cancer	4.21e-05	0.000279	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—kidney cancer	4.21e-05	0.000279	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—kidney cancer	4.2e-05	0.000279	CcSEcCtD
Thiotepa—Nervous system disorder—Capecitabine—kidney cancer	4.19e-05	0.000278	CcSEcCtD
Thiotepa—Thrombocytopenia—Capecitabine—kidney cancer	4.19e-05	0.000278	CcSEcCtD
Thiotepa—Tachycardia—Capecitabine—kidney cancer	4.17e-05	0.000277	CcSEcCtD
Thiotepa—Vomiting—Vincristine—kidney cancer	4.17e-05	0.000277	CcSEcCtD
Thiotepa—Skin disorder—Capecitabine—kidney cancer	4.15e-05	0.000275	CcSEcCtD
Thiotepa—Urticaria—Paclitaxel—kidney cancer	4.14e-05	0.000275	CcSEcCtD
Thiotepa—Rash—Vincristine—kidney cancer	4.14e-05	0.000274	CcSEcCtD
Thiotepa—Dermatitis—Vincristine—kidney cancer	4.13e-05	0.000274	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—kidney cancer	4.12e-05	0.000273	CcSEcCtD
Thiotepa—Abdominal pain—Paclitaxel—kidney cancer	4.12e-05	0.000273	CcSEcCtD
Thiotepa—Body temperature increased—Paclitaxel—kidney cancer	4.12e-05	0.000273	CcSEcCtD
Thiotepa—Headache—Vincristine—kidney cancer	4.11e-05	0.000273	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—kidney cancer	4.09e-05	0.000271	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—kidney cancer	4.08e-05	0.00027	CcSEcCtD
Thiotepa—Anorexia—Capecitabine—kidney cancer	4.08e-05	0.00027	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—kidney cancer	4.03e-05	0.000267	CcSEcCtD
Thiotepa—Vomiting—Gemcitabine—kidney cancer	3.96e-05	0.000262	CcSEcCtD
Thiotepa—Rash—Gemcitabine—kidney cancer	3.92e-05	0.00026	CcSEcCtD
Thiotepa—Dermatitis—Gemcitabine—kidney cancer	3.92e-05	0.00026	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—kidney cancer	3.9e-05	0.000259	CcSEcCtD
Thiotepa—Headache—Gemcitabine—kidney cancer	3.9e-05	0.000259	CcSEcCtD
Thiotepa—Nausea—Vincristine—kidney cancer	3.9e-05	0.000258	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.9e-05	0.000258	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—kidney cancer	3.88e-05	0.000257	CcSEcCtD
Thiotepa—Paraesthesia—Capecitabine—kidney cancer	3.84e-05	0.000255	CcSEcCtD
Thiotepa—Hypersensitivity—Paclitaxel—kidney cancer	3.84e-05	0.000255	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—kidney cancer	3.83e-05	0.000254	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—kidney cancer	3.81e-05	0.000253	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—kidney cancer	3.8e-05	0.000252	CcSEcCtD
Thiotepa—Dyspepsia—Capecitabine—kidney cancer	3.76e-05	0.00025	CcSEcCtD
Thiotepa—Asthenia—Paclitaxel—kidney cancer	3.74e-05	0.000248	CcSEcCtD
Thiotepa—Decreased appetite—Capecitabine—kidney cancer	3.72e-05	0.000247	CcSEcCtD
Thiotepa—Nausea—Gemcitabine—kidney cancer	3.7e-05	0.000245	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Capecitabine—kidney cancer	3.69e-05	0.000245	CcSEcCtD
Thiotepa—Fatigue—Capecitabine—kidney cancer	3.69e-05	0.000245	CcSEcCtD
Thiotepa—Pruritus—Paclitaxel—kidney cancer	3.69e-05	0.000245	CcSEcCtD
Thiotepa—Pain—Capecitabine—kidney cancer	3.66e-05	0.000243	CcSEcCtD
Thiotepa—Constipation—Capecitabine—kidney cancer	3.66e-05	0.000243	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—kidney cancer	3.63e-05	0.00024	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—kidney cancer	3.62e-05	0.00024	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—kidney cancer	3.6e-05	0.000239	CcSEcCtD
Thiotepa—Diarrhoea—Paclitaxel—kidney cancer	3.57e-05	0.000236	CcSEcCtD
Thiotepa—Feeling abnormal—Capecitabine—kidney cancer	3.52e-05	0.000234	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—kidney cancer	3.52e-05	0.000233	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—kidney cancer	3.5e-05	0.000232	CcSEcCtD
Thiotepa—Gastrointestinal pain—Capecitabine—kidney cancer	3.5e-05	0.000232	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—kidney cancer	3.5e-05	0.000232	CcSEcCtD
Thiotepa—Chills—Doxorubicin—kidney cancer	3.48e-05	0.000231	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—kidney cancer	3.47e-05	0.00023	CcSEcCtD
Thiotepa—Dizziness—Paclitaxel—kidney cancer	3.45e-05	0.000229	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—kidney cancer	3.43e-05	0.000227	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—kidney cancer	3.4e-05	0.000225	CcSEcCtD
Thiotepa—Urticaria—Capecitabine—kidney cancer	3.4e-05	0.000225	CcSEcCtD
Thiotepa—Abdominal pain—Capecitabine—kidney cancer	3.38e-05	0.000224	CcSEcCtD
Thiotepa—Body temperature increased—Capecitabine—kidney cancer	3.38e-05	0.000224	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—kidney cancer	3.38e-05	0.000224	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—kidney cancer	3.38e-05	0.000224	CcSEcCtD
Thiotepa—Tension—Doxorubicin—kidney cancer	3.31e-05	0.00022	CcSEcCtD
Thiotepa—Vomiting—Paclitaxel—kidney cancer	3.31e-05	0.00022	CcSEcCtD
Thiotepa—Rash—Paclitaxel—kidney cancer	3.29e-05	0.000218	CcSEcCtD
Thiotepa—Dermatitis—Paclitaxel—kidney cancer	3.28e-05	0.000218	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—kidney cancer	3.28e-05	0.000218	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—kidney cancer	3.27e-05	0.000217	CcSEcCtD
Thiotepa—Headache—Paclitaxel—kidney cancer	3.26e-05	0.000217	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—kidney cancer	3.18e-05	0.000211	CcSEcCtD
Thiotepa—Hypersensitivity—Capecitabine—kidney cancer	3.15e-05	0.000209	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—kidney cancer	3.12e-05	0.000207	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—kidney cancer	3.1e-05	0.000206	CcSEcCtD
Thiotepa—Nausea—Paclitaxel—kidney cancer	3.09e-05	0.000205	CcSEcCtD
Thiotepa—Asthenia—Capecitabine—kidney cancer	3.07e-05	0.000203	CcSEcCtD
Thiotepa—Pruritus—Capecitabine—kidney cancer	3.03e-05	0.000201	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—kidney cancer	3.02e-05	0.000201	CcSEcCtD
Thiotepa—Cough—Doxorubicin—kidney cancer	2.95e-05	0.000195	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—kidney cancer	2.93e-05	0.000194	CcSEcCtD
Thiotepa—Diarrhoea—Capecitabine—kidney cancer	2.93e-05	0.000194	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—kidney cancer	2.92e-05	0.000193	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—kidney cancer	2.88e-05	0.000191	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—kidney cancer	2.88e-05	0.000191	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—kidney cancer	2.87e-05	0.00019	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.86e-05	0.000189	CcSEcCtD
Thiotepa—Dizziness—Capecitabine—kidney cancer	2.83e-05	0.000188	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—kidney cancer	2.78e-05	0.000184	CcSEcCtD
Thiotepa—Infection—Doxorubicin—kidney cancer	2.74e-05	0.000182	CcSEcCtD
Thiotepa—Vomiting—Capecitabine—kidney cancer	2.72e-05	0.00018	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—kidney cancer	2.7e-05	0.000179	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—kidney cancer	2.7e-05	0.000179	CcSEcCtD
Thiotepa—Rash—Capecitabine—kidney cancer	2.7e-05	0.000179	CcSEcCtD
Thiotepa—Dermatitis—Capecitabine—kidney cancer	2.69e-05	0.000179	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—kidney cancer	2.69e-05	0.000178	CcSEcCtD
Thiotepa—Headache—Capecitabine—kidney cancer	2.68e-05	0.000178	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—kidney cancer	2.68e-05	0.000178	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—kidney cancer	2.63e-05	0.000174	CcSEcCtD
Thiotepa—Nausea—Capecitabine—kidney cancer	2.54e-05	0.000168	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.51e-05	0.000167	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—kidney cancer	2.47e-05	0.000164	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—kidney cancer	2.45e-05	0.000163	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—kidney cancer	2.43e-05	0.000161	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—kidney cancer	2.4e-05	0.000159	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.38e-05	0.000158	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—kidney cancer	2.38e-05	0.000158	CcSEcCtD
Thiotepa—Pain—Doxorubicin—kidney cancer	2.36e-05	0.000156	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—kidney cancer	2.36e-05	0.000156	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—kidney cancer	2.27e-05	0.000151	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—kidney cancer	2.25e-05	0.000149	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—kidney cancer	2.19e-05	0.000145	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—kidney cancer	2.18e-05	0.000145	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—kidney cancer	2.18e-05	0.000145	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—kidney cancer	2.03e-05	0.000135	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—kidney cancer	1.98e-05	0.000131	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—kidney cancer	1.95e-05	0.000129	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—kidney cancer	1.89e-05	0.000125	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—kidney cancer	1.82e-05	0.000121	CcSEcCtD
Thiotepa—Vomiting—Doxorubicin—kidney cancer	1.75e-05	0.000116	CcSEcCtD
Thiotepa—Rash—Doxorubicin—kidney cancer	1.74e-05	0.000115	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—kidney cancer	1.74e-05	0.000115	CcSEcCtD
Thiotepa—Headache—Doxorubicin—kidney cancer	1.73e-05	0.000115	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—kidney cancer	1.64e-05	0.000109	CcSEcCtD
